Oral treatment of polioencephalomalacia and subclinical thiamine deficiency with thiamine propyl disulphide and thiamine hydrochloride.
Thiaminase type I production by Bacillus thiaminolyticus and activity in vitro were repressed by the primary substate thiamine and by thiamine monophosphate and thiamine propyl disulphide. At thiamine concentrations of 300-3000 mumol/l production of active enzyme by B. thiaminolyticus, and activity of purified enzyme, were totally repressed. Growth of B. thiaminolyticus was inhibited by thiamine propyl disulphide at 3000 mumol/l. Activity of purified thiaminase was lost when incubated with ruminal fluid from healthy thiaminase free sheep. Enzyme activity was also lost when exposed to mildly alkaline conditions but was stimulated and stabilized against heat denaturation if treated with dithiothreitol. Thiaminase activities in the ruminal fluids of cases of ovine polioencephalomalacia were repressed within 2 h of oral administration of thiamine propyl disulphide. Blood pyruvate levels and transketolase activities were restored to normal following treatment. Treated animals recovered clinically and were returned to pasture.
D000284:Administration, Oral; D019883:Alkyl and Aryl Transferases; D000818:Animals; D001407:Bacillus / Q000201:enzymology / Q000302:isolation & purification*; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy / Q000662:veterinary*; D006867:Hydrolases / Q000378:metabolism*; D007700:Kinetics; D012756:Sheep; D012757:Sheep Diseases / Q000188:drug therapy* / Q000382:microbiology; D013831:Thiamine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D013832:Thiamine Deficiency / Q000188:drug therapy / Q000209:etiology / Q000662:veterinary*; D014018:Tissue Distribution; D014166:Transferases / Q000378:metabolism*
D014166:Transferases; D019883:Alkyl and Aryl Transferases; C022737:thiamin pyridinylase; D006867:Hydrolases; C022731:thiaminase II; C013294:prosultiamine; D013831:Thiamine